Clinical TrialsSearch results
Number of results: 415
Other
- Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
- tachyarrhythmia
- JL-Knight Study Group
- 2007-12-27
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- Phase II study of rituximab in patients with severe systemic lupus erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Recruiting
- Exploratory study for the usefulness of early introduction of anifrolumab in the first remission induction therapy for systemic lupus erythematosus
- systemic lupus erythematosus
- Tsuboi Hiroto
- 2023-09-22
Other
- A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)
- Symptomatic uterine leimoyoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase I/II study of percutaneous radiofrequency ablation for metastatic bone tumor (JIVROSG-0208)
- Symptomatic metastatic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204)
- Symptomatic intrapelvic malignant tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- Randomized study comparing six times of epirubicin instillation for 2.5 months with six times for two weeks in superficial bladder cancer after transurethral resection of bladder tumor
- Superficial bladder cancer
- Japanese Urological Cancer Research Group
- 2005-09-30